Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wisner Baum represents plaintiffs in litigation related to defective pharmaceuticals, medical devices, vaccines, toxic exposure, and more; recent cases cover Zantac cancer litigation, Gardasil vaccine injury, Actos class action (diabetes drug), toxic baby food (heavy metals), and breast cancer risks from antipsychotics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wisner Baum.